SRRA Overview
Upcoming Projects (SRRA)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (SRRA)
-
An Eighth Take: Looking at Momelotinib & Pacritinib in treating Myelofibrosis
Tickers: SRRA, CTIC
Executed On: Jan 21, 2022 at 10:05 AM EST -
A Seventh Take: Looking at Momelotinib & Pacritinib in treating Myelofibrosis
Tickers: SRRA, CTIC
Executed On: Jan 20, 2022 at 05:00 PM EST -
Survey of 25 Physicians: Gauging expectations for Sierra Oncology's MOMENTUM data read out for Momelotinib in Myelofibrosis
Tickers: SRRA, CTIC
Executed On: Jan 20, 2022 at 04:25 PM EST -
A Sixth Take: Looking at Momelotinib & Pacritinib in treating Myelofibrosis
Tickers: SRRA, CTIC
Executed On: Jan 20, 2022 at 10:10 AM EST -
A Fifth Take: Looking at Momelotinib & Pacritinib in treating Myelofibrosis
Tickers: SRRA, CTIC
Executed On: Jan 19, 2022 at 11:00 AM EST -
A Fourth Take: Looking at Momelotinib & Pacritinib in treating Myelofibrosis
Tickers: SRRA, CTIC
Executed On: Jan 17, 2022 at 05:00 PM EST -
A Third Take: Looking at Momelotinib & Pacritinib in treating Myelofibrosis
Tickers: SRRA, CTIC
Executed On: Jan 14, 2022 at 04:00 PM EST -
Another View: Looking at Momelotinib prior to the MOMENTUM readout in anemic myelofibrosis patients who have previously been on JAKi therapy
Ticker: SRRA
Executed On: Jan 14, 2022 at 09:00 AM EST -
A look at Momelotinib prior to the MOMENTUM readout in anemic myelofibrosis patients who have previously been on JAKi therapy
Ticker: SRRA
Executed On: Jan 12, 2022 at 02:00 PM EST
Upcoming & Overdue Catalysts (SRRA)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (SRRA)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
